Madison, WI, United States of America

Brandon Shelley

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Fujifilm Cellular Dynamics, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brandon Shelley. Retrieved from https://idiyas.com/inventor/brandon-shelley-evj72fxf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Brandon Shelley

Introduction

Brandon Shelley is a notable inventor based in Madison, WI (US). He has made significant strides in the field of cellular dynamics, particularly in the differentiation of ocular cells. His work has implications for therapeutic applications, showcasing the potential of stem cell research.

Latest Patents

Brandon Shelley holds a patent titled "Method for differentiation of ocular cells and use thereof." This patent describes methods for producing a photoreceptor precursor (PRP) cell population derived from stem cells. The techniques outlined in this patent are crucial for advancing therapeutic options in ocular health.

Career Highlights

Brandon is currently employed at Fujifilm Cellular Dynamics, Inc., where he continues to push the boundaries of innovation in cellular research. His expertise in stem cell technology has positioned him as a key figure in the development of new therapeutic methods.

Collaborations

Brandon collaborates with talented individuals such as Marisa Fenn and Benjamin Meline. Their combined efforts contribute to the advancement of research in the field of cellular dynamics.

Conclusion

Brandon Shelley exemplifies the spirit of innovation in the realm of ocular cell differentiation. His contributions through patents and collaborative efforts are paving the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…